Loading…
This event has ended. Visit the official site or create your own event on Sched.
Friday, October 6 • 10:15am - 11:00am
Genomics Investment and Market Overview

Log in to save this to your schedule and see who's attending!

Feedback form is now closed.
The overall market for genomic testing is estimated at $8B, growing at a CAGR of 15% to 30%.  Significant advances in the technology and clinical techniques used to read genomes enable more genetic information to be read at lower costs, offering the promise of precision medicine.  The market is currently undergoing a  transition from traditional single gene or small gene panel tests to whole exome sequencing (WES) and whole genome sequencing (WGS). The market for genomic testing in the U.S. is a highly fragmented and little homogeneity in testing techniques.

Speakers
avatar for Steven Mo, PhD

Steven Mo, PhD

VP of Operations and Market Strategy, OptumInsight


Friday October 6, 2017 10:15am - 11:00am
Room 85 Optum, 13625 Technology Drive, Eden Prairie, MN, United States